Cargando…

Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis

Clearance of protein-bound uremic toxins (PBUTs) by dialysis is a challenge in the treatment of uremic patients. Shen-Shuai-Ning (SSN), a traditional Chinese medicine formulation, has been used commonly in China to retard kidney disease progression and decrease uremic toxins in chronic kidney diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xujiao, Gao, Shouhong, Ruan, Mengna, Chen, Sixiu, Xu, Jing, Xing, Xiaohong, Pan, Xiaohong, Mei, Changlin, Mao, Zhiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137246/
https://www.ncbi.nlm.nih.gov/pubmed/29921575
http://dx.doi.org/10.1042/BSR20171694
_version_ 1783355149404602368
author Chen, Xujiao
Gao, Shouhong
Ruan, Mengna
Chen, Sixiu
Xu, Jing
Xing, Xiaohong
Pan, Xiaohong
Mei, Changlin
Mao, Zhiguo
author_facet Chen, Xujiao
Gao, Shouhong
Ruan, Mengna
Chen, Sixiu
Xu, Jing
Xing, Xiaohong
Pan, Xiaohong
Mei, Changlin
Mao, Zhiguo
author_sort Chen, Xujiao
collection PubMed
description Clearance of protein-bound uremic toxins (PBUTs) by dialysis is a challenge in the treatment of uremic patients. Shen-Shuai-Ning (SSN), a traditional Chinese medicine formulation, has been used commonly in China to retard kidney disease progression and decrease uremic toxins in chronic kidney disease (CKD) patients, but the effects of SSN on serum PBUTs in dialysis patients were not investigated. We conducted a randomized controlled trial in patients on peritoneal dialysis (PD) at dialysis center of Changzheng Hospital to evaluate the effects of SSN on serum PBUTs. Participants with SSN intervention took 5 g SSN granule three times daily for 12 weeks, while the baseline medications and dialysis prescriptions remained during the study in all patients. The serum concentrations of indoxyl sulphate (IS) and p-cresol sulphate (PCS) were determined by HPLC/MS/MS and biochemical parameters were assessed during the study. Sixty PD patients were enrolled and randomly allocated into SSN group and control group. Total IS level was significantly lower in SSN group than in control group at week 4, 8, and 12 (27.28 ± 18.19, 29.73 ± 19.10, and 29.41 ± 17.61 mg/l compared with 39.25 ± 20.23, 44.86 ± 23.91, and 45.34 ± 33.52 mg/l, respectively). However, there were no statistical difference of total PCS, free forms of IS and PCS concentrations between SSN group and control group during 12 weeks follow-up. Administration of SSN granule orally decreased serum total IS level effectively in uremic patients on PD with good tolerance. Benefits of PD patients’ outcomes from IS reduction by SSN awaits further large size and long duration clinical trials to verify.
format Online
Article
Text
id pubmed-6137246
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-61372462018-09-18 Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis Chen, Xujiao Gao, Shouhong Ruan, Mengna Chen, Sixiu Xu, Jing Xing, Xiaohong Pan, Xiaohong Mei, Changlin Mao, Zhiguo Biosci Rep Research Articles Clearance of protein-bound uremic toxins (PBUTs) by dialysis is a challenge in the treatment of uremic patients. Shen-Shuai-Ning (SSN), a traditional Chinese medicine formulation, has been used commonly in China to retard kidney disease progression and decrease uremic toxins in chronic kidney disease (CKD) patients, but the effects of SSN on serum PBUTs in dialysis patients were not investigated. We conducted a randomized controlled trial in patients on peritoneal dialysis (PD) at dialysis center of Changzheng Hospital to evaluate the effects of SSN on serum PBUTs. Participants with SSN intervention took 5 g SSN granule three times daily for 12 weeks, while the baseline medications and dialysis prescriptions remained during the study in all patients. The serum concentrations of indoxyl sulphate (IS) and p-cresol sulphate (PCS) were determined by HPLC/MS/MS and biochemical parameters were assessed during the study. Sixty PD patients were enrolled and randomly allocated into SSN group and control group. Total IS level was significantly lower in SSN group than in control group at week 4, 8, and 12 (27.28 ± 18.19, 29.73 ± 19.10, and 29.41 ± 17.61 mg/l compared with 39.25 ± 20.23, 44.86 ± 23.91, and 45.34 ± 33.52 mg/l, respectively). However, there were no statistical difference of total PCS, free forms of IS and PCS concentrations between SSN group and control group during 12 weeks follow-up. Administration of SSN granule orally decreased serum total IS level effectively in uremic patients on PD with good tolerance. Benefits of PD patients’ outcomes from IS reduction by SSN awaits further large size and long duration clinical trials to verify. Portland Press Ltd. 2018-09-14 /pmc/articles/PMC6137246/ /pubmed/29921575 http://dx.doi.org/10.1042/BSR20171694 Text en © 2018 The Author(s). http://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Articles
Chen, Xujiao
Gao, Shouhong
Ruan, Mengna
Chen, Sixiu
Xu, Jing
Xing, Xiaohong
Pan, Xiaohong
Mei, Changlin
Mao, Zhiguo
Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
title Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
title_full Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
title_fullStr Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
title_full_unstemmed Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
title_short Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
title_sort shen-shuai-ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137246/
https://www.ncbi.nlm.nih.gov/pubmed/29921575
http://dx.doi.org/10.1042/BSR20171694
work_keys_str_mv AT chenxujiao shenshuaininggranuledecreasedserumconcentrationsofindoxylsulphateinuremicpatientsundergoingperitonealdialysis
AT gaoshouhong shenshuaininggranuledecreasedserumconcentrationsofindoxylsulphateinuremicpatientsundergoingperitonealdialysis
AT ruanmengna shenshuaininggranuledecreasedserumconcentrationsofindoxylsulphateinuremicpatientsundergoingperitonealdialysis
AT chensixiu shenshuaininggranuledecreasedserumconcentrationsofindoxylsulphateinuremicpatientsundergoingperitonealdialysis
AT xujing shenshuaininggranuledecreasedserumconcentrationsofindoxylsulphateinuremicpatientsundergoingperitonealdialysis
AT xingxiaohong shenshuaininggranuledecreasedserumconcentrationsofindoxylsulphateinuremicpatientsundergoingperitonealdialysis
AT panxiaohong shenshuaininggranuledecreasedserumconcentrationsofindoxylsulphateinuremicpatientsundergoingperitonealdialysis
AT meichanglin shenshuaininggranuledecreasedserumconcentrationsofindoxylsulphateinuremicpatientsundergoingperitonealdialysis
AT maozhiguo shenshuaininggranuledecreasedserumconcentrationsofindoxylsulphateinuremicpatientsundergoingperitonealdialysis